Update on the efficacy and safety of Petadolex^®, a butterbur extract for migraine prophylaxis

References

• World Health Organization. Global Burden of Disease. Geneva, Switzerland: World Health Organization; 2000. Available from: http://www.who.int/healthinfo/global_burden_disease/en/. Accessed November 29, 2011.
   Google Scholar
• World Health Organization. Global Burden of Disease. 2004 Update. Geneva, Switzerland: World Health Organization; 2004. Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Accessed November 29, 2013.
   Google Scholar
• Antonaci F, Nappi G, Galli F, Manzoni GC, Calabresi P, Costa A. Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain. 2011;12(2):115–125.
   PubMed Web of Science ®Google Scholar
• Charles A. The evolution of a migraine attack – a review of recent evidence. Headache. 2013;53(2):413–419.
   PubMed Web of Science ®Google Scholar
• Bekkelund SI, Alstadhaug KB. Migraine prophylactic drugs – something new under the sun? Expert Opin Investig Drugs. 2011;20(9):1201–1210.
   PubMed Web of Science ®Google Scholar
• National Health Service. Migraine; 2013. Available from: http://www.nhs.uk/Conditions/Migraine/Pages/Introduction.aspx. Accessed November 29, 2013.
   Google Scholar
• Laurell K, Larsson B, Eeg-Olofsson O. Prevalence of headache in Swedish schoolchildren, with a focus on tension-type headache. Cephalalgia. 2004;24(5):380–388.
   Web of Science ®Google Scholar
• Egermark-Eriksson I. Prevalence of headache in Swedish schoolchildren. A questionnaire survey. Acta Paediatr Scand. 1982;71(1):135–140.
   Web of Science ®Google Scholar
• Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache. 2013;53(2):230–246.
   PubMed Web of Science ®Google Scholar
• Sillanpaa M, Anttila P. Increasing prevalence of headache in 7-year-old schoolchildren. Headache. 1996;36(8):466–470.
   PubMed Web of Science ®Google Scholar
• Oelkers-Ax R, Leins A, Parzer P, et al. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain. 2008;12(3):301–313.
   Web of Science ®Google Scholar
• Schulman E, McGeeney BE. Current concepts in refractory migraine. Curr Treat Options Neurol. 2013;15(1):40–55.
   Web of Science ®Google Scholar
• Barbanti P, Aurilia C, Egeo G, Fofi L. Migraine prophylaxis: what is new and what we need? Neurol Sci. 2011;32 Suppl 1:S111–S115.
   Google Scholar
• Stovner LJ, Tronvik E, Hagen K. New drugs for migraine. J Headache Pain. 2009;10(6):395–406.
   Web of Science ®Google Scholar
• Shamliyan TA, Choi JY, Ramakrishnan R, et al. Preventive pharmacologic treatments for episodic migraine in adults. J Gen Intern Med. 2013;28(9):1225–1237.
   Web of Science ®Google Scholar
• Schiapparelli P, Allais G, Castagnoli Gabellari I, Rolando S, Terzi MG, Benedetto C. Non-pharmacological approach to migraine prophylaxis: part II. Neurol Sci. 2010;31 Suppl 1:S137–S139.
   Google Scholar
• Grazzi L, Andrasik F. Non-pharmacological approaches in migraine prophylaxis: behavioral medicine. Neurol Sci. 2010;31 Suppl 1:S133–S135.
   Google Scholar
• Sun-Edelstein C, Mauskop A. Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache. 2011;51(3):469–483.
   Web of Science ®Google Scholar
• Evans RW, Taylor FR. “Natural” or alternative medications for migraine prevention. Headache. 2006;46(6):1012–1018.
   Web of Science ®Google Scholar
• Aydin AA, Zerbes V, Parlar H, Letzel T. The medical plant butterbur (Petasites): analytical and physiological (re)view. J Pharm Biomed Anal. 2013;75:220–229.
   PubMed Web of Science ®Google Scholar
• Galeotti N, Ghelardini C. St John’s wort relieves pain in an animal model of migraine. Eur J Pain. 2013;17(3):369–381.
   Web of Science ®Google Scholar
• Murch SJ, Simmons CB, Saxena PK. Melatonin in feverfew and other medicinal plants. Lancet. 1997;350(9091):1598–1599.
   Web of Science ®Google Scholar
• Esposito M, Carotenuto M. Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study. Neurol Sci. 2011;32(1):79–81.
   Web of Science ®Google Scholar
• Singh P, Singh IN, Mondal SC, Singh L, Garg VK. Platelet-activating factor (PAF)-antagonists of natural origin. Fitoterapia. 2013;84:180–201.
   PubMed Web of Science ®Google Scholar
• Strømgaard K. Medicinal chemistry of ginkgolides from ginkgo biloba. In: Liang X, Fang WS, editors. Medicinal Chemistry of Bioactive Natural Products. Hoboken, NJ, USA: Wiley-Interscience/John Wiley; 2006.
   Google Scholar
• Sarchielli P, Alberti A, Coppola F, et al. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. Cephalalgia. 2004;24(8):623–630.
   Web of Science ®Google Scholar
• Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2004;1:CD002286.
   Web of Science ®Google Scholar
• Mirzaei MG, Sewell RDE, Kheiri S, Rafieian-Kopaei M. A clinical trial of the effect of St John’s wort on migraine headaches in patients receiving sodium valproate. J Med Plants Res. 2012;6(9):1519–1523.
   Google Scholar
• Usai S, Grazzi L, Bussone G. Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up. Neurol Sci. 2011; 32 Suppl 1:S197–S199.
   Google Scholar
• Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol. 2004;51(2):89–97.
   PubMed Web of Science ®Google Scholar
• Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther. 2000;38(9):430–435.
   PubMed Web of Science ®Google Scholar
• Grossmann W, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Altern Med Rev. 2001;6(3):303–310.
   Google Scholar
• Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240–2244.
   PubMed Web of Science ®Google Scholar
• Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache. 2005;45(3):196–203.
   Google Scholar
• Williamson EM. Potter’s Herbal Cyclopaedia: Saffron Walden, UK: The CW Daniel Company Limited; 2003.
   Google Scholar
• Royal Botanic Garden Edinburgh. Flora Europaea. Available from: http://rbg-web2.rbge.org.uk/FE/fe.html. Accessed November 29, 2013.
   Google Scholar
• Duke JA. Dr Duke’s Phytochemical and Ethnobotanical Databases. Available from: http://www.ars-grin.gov/duke/chem-activities.html. Accessed November 29, 2013.
   Google Scholar
• US Department of Agriculture. Petasites hybridus (L.) G Gaertn, et al. 2012. Available from: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl?Petasites%20hybridus. Accessed November 29, 2013.
   Google Scholar
• Danesch UC. Petasites hybridus (butterbur root) extract in the treatment of asthma – an open trial. Altern Med Rev. 2004;9(1):54–62.
   PubMedGoogle Scholar
• Ziolo G, Samochowiec L. Study on clinical properties and mechanisms of action of Petasites in bronchial asthma and chronic obstructive bronchitis. Pharm Acta Helv. 1998;72(6):378–380.
   Google Scholar
• de Souza Carvalho D, Fragoso YD, Coelho FM, Pereira MM. Asthma plus migraine in childhood and adolescence: prophylactic benefits with leukotriene receptor antagonist. Headache. 2002;42(10):1044–1047.
   Web of Science ®Google Scholar
• Low NC, Merikangas KR. The comorbidity of migraine. CNS Spectr. 2003;8(6):433–434, 437–444.
   Web of Science ®Google Scholar
• LaMancusa R, Pulcinelli FM, Ferroni P, et al. Blood leukotrienes in headache: correlation with platelet activity. Headache. 1991;31(6):409–414.
   Web of Science ®Google Scholar
• Parantainen J, Vapaatalo H, Hokkanen E. Clinical aspects of prostaglandins and leukotrienes in migraine. Cephalalgia. 1986;6 Suppl 4:95–101.
   Google Scholar
• Thomet OA, Schapowal A, Heinisch IV, Wiesmann UN, Simon HU. Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis. Int Immunopharmacol. 2002;2(7):997–1006.
   PubMed Web of Science ®Google Scholar
• Thomet OA, Simon HU. Petasins in the treatment of allergic diseases: results of preclinical and clinical studies. Int Arch Allergy Immunol. 2002;129(2):108–112.
   PubMed Web of Science ®Google Scholar
• Bickel D, Röder T, Bestmann HJ, Brune K. Identification and characterization of inhibitors of peptido-leukotriene-synthesis from petasites hybridus. Planta Med. 1994;60(4):318–322.
   PubMed Web of Science ®Google Scholar
• Sheftell F, Rapoport A, Weeks R, Walker B, Gammerman I, Baskin S. Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Headache. 2000;40(2):158–163.
   PubMed Web of Science ®Google Scholar
• Brandes JL, Visser WH, Farmer MV, et al. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache. 2004;44(6):581–586.
   Web of Science ®Google Scholar
• Ku M, Silverman B, Prifti N, Ying W, Persaud Y, Schneider A. Prevalence of migraine headaches in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2006;97(2):226–230.
   PubMed Web of Science ®Google Scholar
• Mehle ME. Migraine and allergy: a review and clinical update. Curr Allergy Asthma Rep. 2012;12(3):240–245.
   PubMed Web of Science ®Google Scholar
• Thomas WA, Butler S. Intravenous histamine in the treatment of migraine. Bull N Y Acad Med. 1946;22(3):125–136.
   Google Scholar
• Mosihuzzaman M. Herbal medicine in healthcare-an overview. Nat Prod Commun. 2012;7(6):807–812.
   Web of Science ®Google Scholar
• McLean EK. The toxic actions of pyrrolizidine (senecio) alkaloids. Pharmacol Rev. 1970;22(4):429–483.
   Google Scholar
• European Medicines Agency. Working Party on Community Monographs and Community List. Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs). 2012. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2013/11/WC500154224.pdf. Accessed November 29, 2013.
   Google Scholar
• Fu P, Xia Q, Lin G, Chou M. Genotoxic pyrrolizidine alkaloids – mechanisms leading to DNA adduct formation and tumorigenicity. Int J Mol Sci. 2002;3(9):948–964.
   Web of Science ®Google Scholar
• SwissMedic. Médicaments contenant de la pétasite (Extractum Petasitidis) et risque de lésions hépatiques graves: procédure de réexamen en vertu de l’art. 16, al. 2, et de l’art. 58, al. 3, de la loi sur les produits thérapeutiques (LPTh). [Medicines containing Petasites (Extractum Petasitidis) and serious liver toxicity risk: revision on the grounds of articles 16_2 and 58_3 of the Therapeutic Products Act.] Swissmedic Journal. 2002(6):392.
   Google Scholar
• Bauer R. Recent progress in the research on traditional herbal medicinal products. Revista de Fitoterapia. 2006;6 Suppl 1:31–35.
   Google Scholar
• Avula B, Wang YH, Wang M, Smillie TJ, Khan IA. Simultaneous determination of sesquiterpenes and pyrrolizidine alkaloids from the rhizomes of Petasites hybridus (L.) GM et Sch and dietary supplements using UPLC-UV and HPLC-TOF-MS methods. J Pharm Biomed Anal. 2012;70:53–63.
   PubMed Web of Science ®Google Scholar
• Linpharma Inc. Petadolex®. Oldsmar, FL, USA: Linpharma Inc; 2013. Available from: http://www.petadolex.com. Accessed November 4, 2013.
   Google Scholar
• Koch V, Rittinghauser R. Composition containing pyrrolizidine-alkaloid-free petasites. US Patent 6,551,626 B1. 2003.
   Google Scholar
• Chrubasik JE, Duke RK, Chrubasik S. Mise à jour de la monographie allemande de la commission E sur Petasites hybridus (pétasite officinal). [Update of the German Commission E Monograph on Petasites hybridus (petasites officinal)] Phytothérapie. 2007;5(3):135–136.
   Google Scholar
• Agosti R, Duke RK, Chrubasik JE, Chrubasik S. Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review. Phytomedicine. 2006;13(9–10):743–746.
   Web of Science ®Google Scholar
• Zellermedical. Tesalin™. Romanshorn, Switzerland: Max Zeller Söhne AG, 2012. Available from: http://zellermedical.ch/products/tesalinn/. Accessed November 29, 2013. German.
   Google Scholar
• Schapowal A, Petasites Study G. Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent efficacy in a prospective, randomized, double-blind, placebo-controlled study. Arch Otolaryngol Head Neck Surg. 2004;130(12):1381–1386.
   Google Scholar
• Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1346–1353.
   PubMed Web of Science ®Google Scholar
• Mauskop A. Safety of Petasites (butterbur). Response to “Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society”. Neurology. 2012;80(9):868–869.
   Web of Science ®Google Scholar
• Tfelt-Hansen PC. Problematic recommendations in ANN’s guidelines on drug prevention of migraine. Response to “Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society”. Neurology. 2012;80(9):869–870.
   Web of Science ®Google Scholar
• Haag G, Diener HC, May A, et al. Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migrane und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft fur Neurologie (DGN), the Osterreichische Kopfschmerzgesellschaft (OKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain. 2011;12(2):201–217.
   Web of Science ®Google Scholar
• Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis – a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia. 2002;22(7):523–532.
   PubMed Web of Science ®Google Scholar
• Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg tid feverfew CO2-extract (MIG-99) in migraine prevention – a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia. 2005;25(11):1031–1041.
   PubMed Web of Science ®Google Scholar
• Usai S, Grazzi L, Andrasik F, Bussone G. An innovative approach for migraine prevention in young age: a preliminary study. Neurol Sci. 2010;31 Suppl 1:S181–S183.
   Google Scholar
• D’Andrea G, Bussone G, Allais G, et al. Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci. 2009;30 Suppl 1:S121–S124.
   Google Scholar
• Danesch U, Rittinghausen R. Safety of a patented special butterbur root extract for migraine prevention. Headache. 2003;43(1):76–78.
   PubMed Web of Science ®Google Scholar
• Gaul C, van Doorn C, Webering N, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain. 2011;12(4):475–483.
   PubMed Web of Science ®Google Scholar
• Kalin P. [The common butterbur (Petasites hybridus) – portrait of a medicinal herb]. Forsch Komplementarmed Klass Naturheilkd. 2003;10 Suppl 1:41–44. German.
   Google Scholar
• Swissmedic. Revocation de l’Authorisation de mis sur le marche (AMM) de certains medicaments contenant du petasite. [Withdrawal of the Product License (PL) of some medicines containing Petasites] SwissMedic Journal. 2004;3(1):22. French.
   Google Scholar
• Weber & Weber. Information: Petadolex® capsules extinguished approval for formal reasons; 2009. Available from: http://www.weber-weber.de. Accessed November 4, 2013.
   Google Scholar